Cognitive Reappraisal Intervention for Suicide Prevention for Suicide Prevention
Study Summary
This trial is testing a new intervention to reduce suicide risk for adults aged 50-90 who have been hospitalized for suicidal thoughts or attempts.
- Suicide Prevention
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Are there any vacancies available for potential participants of this medical experiment?
"Affirmative. According to clinicaltrials.gov, the research is accepting new participants and was first posted on March 28th 2017 with a recent update on May 17th 2022. The trial needs 90 individuals from one centre to take part in this investigation."
Does the age of applicants have any bearing on eligibility for this clinical experiment?
"This medical trial requires patients to be between the ages of 50 and 90. In contrast, there are 57 trials for those younger than 18 years old and 117 for seniors exceeding 65 years of age."
How many participants are receiving treatment through this clinical trial?
"Affirmative. Patient recruitment for this clinical trial is ongoing, as seen on the listing posted to clinicaltrials.gov dated March 28th 2017 and updated May 17th 2022. This experiment needs 90 participants from a single medical center."
Am I able to enroll in this experiment?
"This medical trial seeks 90 elderly individuals aged between 50 and 90 who are suffering from depression or anxiety. The DSM-5 diagnosis criteria (from the SCID-5 Clinical Trials Version) must be used to determine patient eligibility."